Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-01 2:44 pm Purchase | 2021-12-31 | 13G | Travere Therapeutics, Inc. TVTX | GOLDMAN SACHS GROUP INC GS | 4,599,279 7.500% | 4,599,279 (New Position) | Filing History |
| 2021-08-13 4:27 pm Purchase | 2021-08-04 | 13G | Travere Therapeutics, Inc. TVTX | Deep Track Capital, LP | 3,090,200 5.090% | 3,090,200 (New Position) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | Travere Therapeutics, Inc. TVTX | RA Capital Management, L.P. | 4,557,867 8.900% | 4,557,867 (New Position) | Filing History |
| 2021-02-16 3:30 pm Purchase | 2020-12-31 | 13G | Travere Therapeutics, Inc. TVTX | Perceptive Advisors LLC | 3,493,607 6.800% | 3,493,607 (New Position) | Filing History |
| 2021-02-16 2:40 pm Sale | 2020-12-31 | 13G | RETROPHIN, INC. RTRX | Consonance Capital Management LP | 0 0.000% | -2,314,421 (Position Closed) | Filing History |
| 2021-02-12 3:48 pm Purchase | 2020-12-31 | 13G | Travere Therapeutics, Inc. TVTX | JANUS HENDERSON GROUP PLC JHG | 4,083,553 8.000% | 4,083,553 (New Position) | Filing History |
| 2021-02-12 08:41 am Purchase | 2020-12-31 | 13G | Travere Therapeutics, Inc. TVTX | Macquarie Group Limited | 2,763,922 5.410% | 2,763,922 (New Position) | Filing History |
| 2021-02-11 4:31 pm Purchase | 2020-12-31 | 13G | Travere Therapeutics, Inc. TVTX | Integrated Core Strategies (US) LLC | 727,176 1.400% | 727,176 (New Position) | Filing History |
| 2021-02-10 11:57 am Purchase | 2020-12-31 | 13G | Travere Therapeutics, Inc. TVTX | The Vanguard Group | 3,404,443 6.670% | 3,404,443 (New Position) | Filing History |
| 2021-02-03 8:55 pm Purchase | 2020-12-31 | 13G | Travere Therapeutics, Inc. TVTX | Manulife Financial Corporation | 2,157,055 11.000% | 2,157,055 (New Position) | Filing History |
| 2021-02-01 08:17 am Purchase | 2020-12-31 | 13G | Travere Therapeutics, Inc. TVTX | BlackRock Inc. BLK | 4,825,174 9.500% | 4,825,174 (New Position) | Filing History |